01061 ESSEX BIO-TECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.11X | Oper Margin | 23.3% |
|---|---|---|---|
| LT Debt/Equity | 11.5% | Net Margin | 17.5% |
| Total Debt/Equity | 14.4% | Return on Equity | 13.2% |
| Price/Book | 0.85X | Return on Assets | 9.1% |
| (HKD 3.620) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 318.09 | 307.22 | 275.26 | 225.41 | 345.97 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +3.5 | +11.6 | +22.1 | -34.9 | +58.0 |
| Earnings Per Share (HKD) | 0.561 | 0.541 | 0.483 | 0.393 | 0.6 |
| Earnings Per Share Growth (%) | +3.6 | +12.2 | +22.9 | -34.6 | +58.4 |
| Dividend Per Share (HKD) | 0.140 | 0.120 | 0.090 | 0.065 | 0.095 |
| P/E* (X) | 6.45 | 6.69 | 7.50 | 9.22 | 6.03 |
| Yield (%) | 3.87 | 3.31 | 2.49 | 1.80 | 2.62 |
| Dividend Share (%) | 24.96 | 22.16 | 18.65 | 16.55 | 15.83 |
| Book NAV (HKD) | 4.256 | 3.745 | 3.389 | 3.029 | 3.013 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,814 | 1,670 | +8.6 | 1,737 |
| Operating Result | 414.824 | 378.411 | +9.6 | 347.655 |
| Associates | -0.162 | -2.911 | -94.4 | -1.641 |
| Profit Before Taxation | 414.662 | 375.5 | +10.4 | 346.014 |
| Taxation | 96.571 | 68.278 | +41.4 | 70.755 |
| Profit /( Loss) After Taxation | 318.091 | 307.222 | +3.5 | 275.259 |
| Net Profit | 318.091 | 307.222 | +3.5 | 275.26 |
| Earnings Per Share () | 0.5610 | 0.5414 | +3.6 | 0.4827 |
| Dividend Per Share () | 0.1400 | 0.1200 | +16.7 | 0.0900 |
| Announcement Date | 2026-03-23 | 2025-03-26 | NA | 2024-03-18 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
